DMD rs886044325: Understanding This Genetic Variant
The genetic variant rs886044325 is a specific alteration located within the DMD gene. It has been identified in clinical research as a pathogenic marker associated with Duchenne and Becker muscular dystrophy.
What each genotype means
Carrier of insertion variant
This genotype indicates the presence of an insertion of two guanine nucleotides (GG) on one chromosome. This specific variant is classified as pathogenic in clinical databases and is associated with Duchenne and Becker muscular dystrophy; please consult with a medical geneticist or clinician to understand the clinical implications for your health.
This specific insertion is rare in the general population.
Homozygous for insertion variant
This genotype indicates the presence of the GG insertion on both chromosomes. This variant is documented in clinical databases as pathogenic and linked to Duchenne and Becker muscular dystrophy; please discuss these findings with a qualified healthcare provider or genetic counselor.
This genotype is extremely rare in the general population.
What is rs886044325?
The identifier rs886044325 refers to a specific genetic variation cataloged in the dbSNP database. Unlike common single nucleotide polymorphisms (SNPs) that involve a simple swap of one DNA letter for another, this variant is characterized as an insertion. Specifically, it involves the addition of two guanine (G) nucleotides into the DNA sequence of the DMD gene. Because this insertion occurs within a gene responsible for producing a critical protein, it can disrupt the normal reading frame of the genetic code. This type of mutation is often referred to as a frameshift mutation, which can lead to the production of a truncated or non-functional protein. Geneticists track such variants to understand how specific changes in the DNA sequence contribute to inherited conditions.
The Role of the DMD Gene
The DMD gene provides instructions for making a protein called dystrophin. Dystrophin is a vital component of a protein complex that works to strengthen muscle fibers and protect them from injury as muscles contract and relax. The protein acts like a shock absorber, maintaining the structural integrity of muscle cells. When the DMD gene contains a mutation that prevents the production of functional dystrophin, muscle cells become damaged over time. This damage leads to the progressive muscle weakness and degeneration characteristic of muscular dystrophies. Because the DMD gene is located on the X chromosome, mutations in this gene primarily affect males, who have only one X chromosome, though females can also be carriers or exhibit symptoms depending on the nature of the genetic change.
Clinical Associations and Evidence
Research documented in clinical databases, such as ClinVar, classifies rs886044325 as a pathogenic variant. This classification indicates that there is strong clinical evidence linking this specific insertion to the development of Duchenne muscular dystrophy and Becker muscular dystrophy. Duchenne muscular dystrophy is a severe form of the condition characterized by early-onset muscle weakness, while Becker muscular dystrophy is generally a milder form with a later onset. The evidence for this variant is derived from clinical observations where individuals presenting with symptoms of muscular dystrophy were found to carry this specific genetic alteration. It is important to note that while this variant is associated with these conditions, the clinical expression can vary between individuals. Genetic testing results should always be interpreted by a qualified medical geneticist or healthcare provider who can correlate the findings with a patient's physical symptoms and family history.
Understanding Your Results
If you have received information about this variant from a genetic testing report, it is essential to understand that this is a clinical finding that requires professional medical context. You cannot use this information to self-diagnose or predict the exact progression of a condition. Because this variant is linked to serious health outcomes, it is strongly recommended that you discuss these results with a physician, genetic counselor, or a specialist in neuromuscular disorders. These professionals can provide accurate information regarding the implications of the variant, discuss potential screening or management options, and offer guidance on how this information might affect other family members. Never make changes to your health management or medical care based solely on a report without consulting your clinical care team.
How common is this variant?
This variant is rare in the general population and is primarily identified in clinical settings among individuals undergoing diagnostic testing for muscular dystrophy.
Frequently asked questions
What does it mean if a variant is classified as pathogenic?
A pathogenic classification means that there is substantial scientific and clinical evidence that the variant is responsible for causing a specific genetic disease or condition.
Can I use this information to predict my health?
No. Genetic variants must be interpreted in the context of your overall health, physical symptoms, and family history by a qualified medical professional.
Is this variant found in everyone?
No, this is a rare genetic variant. Most people do not carry this specific insertion in their DMD gene.
Who should I talk to about these results?
You should discuss these results with a genetic counselor, a medical geneticist, or your primary care physician who can provide appropriate clinical guidance.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886044325?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the HLA-DQB1 region is associated with peanut allergy susceptibility, reflecting the broader role of HLA class II variation in food allergy risk.
This variant is a robustly replicated genetic marker associated with short sleep duration across diverse ancestral populations.
This variant in the TYK2 gene is identified as a shared causal signal in the genetic architecture of psoriasis and rheumatoid arthritis.
This TYK2 variant shows evidence of antagonistic pleiotropy, with opposite effects on the risk of psoriasis versus rheumatoid arthritis.
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.